Black Diamond Therapeutics
(NASDAQ) BDTX
Black Diamond Therapeutics Financials at a Glance
Market Cap
$122.02M
Revenue (TTM)
$70.00M
Net Income (TTM)
$22.37M
EPS (TTM)
$0.38
P/E Ratio
5.60
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Price
$2.33
Volume
1,097,927.14
Open
$2.16
Price
$2.33
Volume
1,097,927.14
Open
$2.16
Previous Close
$2.33
Daily Range
$2.16 - $2.38
52-Week Range
$1.20 - $4.94
Dividend
$0.00
Beta (Volatility)
1.51 (High)
Price
$2.33
Volume
1,097,927.14
Open
$2.16
Previous Close
$2.33
Daily Range
$2.16 - $2.38
52-Week Range
$1.20 - $4.94
BDTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Black Diamond Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
21
CEO
Mark A. Velleca, MD, PhD
Headquarters
Cambridge, MA 02142, US
BDTX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
28%
Net Income Margin
32%
Return on Equity
23%
Return on Capital
16%
Return on Assets
16%
Earnings Yield
17.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$122.02M
Shares Outstanding
57.29M
Volume
1.10M
Short Interest
0.00%
Avg. Volume
725.70K
Financials (TTM)
Gross Profit
$69.67M
Operating Income
$19.87M
EBITDA
$20.20M
Operating Cash Flow
$29.61M
Capital Expenditure
$0.00
Free Cash Flow
$29.61M
Cash & ST Invst.
$128.65M
Total Debt
$15.07M
Black Diamond Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$66.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$122.02M
N/A
Market Cap/Employee
$5.08M
N/A
Employees
24
N/A
Net Income
$15.12M
+5.4%
EBITDA
$10.20M
+43.9%
Quarterly Fundamentals
Net Cash
$113.58M
+48.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$15.07M
-19.8%
Short Term Debt
$0.00
-100.0%
Return on Assets
15.64%
N/A
Return on Invested Capital
15.61%
N/A
Free Cash Flow
$6.79M
+54.9%
Operating Cash Flow
$6.79M
+54.9%